Early lymphaticovenous anastomosis in lymphedema management: a pilot study

Abstract

Aim: Lymphedema is a progressive degenerative disease that can cause severe swelling and recurrent infections. Conservative and surgical treatments, such as lymphaticovenous anastomosis (LVA), are available; however, the optimal timing for LVA after the initiation of complex decongestive therapy (CDT) remains unclear. This study aimed to evaluate the effect of CDT duration prior to LVA on the treatment outcomes of upper extremity lymphedema.

Methods: Fifty patients with stage II upper extremity lymphedema who underwent LVA were retrospectively evaluated. Patients were divided into two groups based on the duration of CDT before LVA: < 6 months (early group) and > 6 months (non-early group). The primary outcome measures were percent excess volume (PEV) and reduction rate 12 months after LVA.

Results: The early group (CDT < 6 months) showed significantly better outcomes than the non-early group (CDT > 6 months). The early group had a lower PEV (4%) and a higher reduction rate (56%) than the non-early group (PEV of 10% and reduction rate of 25%) at 12 months after LVA.

Conclusions: Early indication for LVA (within 6 months of CDT initiation) resulted in better treatment outcomes for stage II upper extremity lymphedema. This study highlights the potential benefits of early surgical intervention for improving the prognosis of lymphedema.

Keywords

Lymphedema / complex decongestive therapy / CDT / lymphaticovenular anastomosis / LVA / early intervention / early surgical indication

References

[1] Document C.The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the international society of lymphology.Lymphology2020;53:3-19.

[2] Campisi CC,Boccardo F.A single-site technique of multiple lymphatic-venous anastomoses for the treatment of peripheral lymphedema: long-term clinical outcome.J Reconstr Microsurg2016;32:42-9

[3] Lee B,Bergan J.Diagnosis and treatment of primary lymphedema. Consensus document of the international union of phlebology (IUP)-2009.Int Angiol2010;29:454-70

[4] Lee BB,Neville R.Current status of lymphatic reconstructive surgery for chronic lymphedema: it is still an uphill battle!.Int J Angiol2011;20:73-80. PMCID:PMC3331640

[5] Scaglioni MF,Fritsche E.Lymphaticovenous anastomosis (LVA) for breast cancer-related lymphedema treatment.Transl Cancer Res2020;9:3167-71. PMCID:PMC8798836

[6] Yamamoto T,Hara H,Narushima M.Upper extremity lymphedema index: a simple method for severity evaluation of upper extremity lymphedema.Ann Plast Surg2013;70:47-9

[7] Kanda Y.Investigation of the freely available easy-to-use software 'EZR' for medical statistics.Bone Marrow Transplant2013;48:452-8 PMCID:PMC3590441

[8] Jayasree P.Diagnosis and management of secondary lymphedema.JSSTD2021;3:16-25

[9] Hwang JH,Lee JY.Lymphscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema.Lymphology2007;40:172-6

[10] Soga S,Jinzaki M,Minabe T.Analysis of collateral lymphatic circulation in patients with lower limb lymphedema using magnetic resonance lymphangiography.J Vasc Surg Venous Lymphat Disord2021;9:471-81.e1.

[11] Garza R 3rd,Hock K.A comprehensive overview on the surgical management of secondary lymphedema of the upper and lower extremities related to prior oncologic therapies.BMC Cancer2017;17:468 PMCID:PMC5497342

[12] Winters H,Hameeteman M.The efficacy of lymphaticovenular anastomosis in breast cancer-related lymphedema.Breast Cancer Res Treat2017;165:321-7 PMCID:PMC5543202

[13] Howarth DM.Increased lymphoscintigraphic flow pattern in the lower extremity under evaluation for lymphedema.Mayo Clin Proc1997;72:423-9

[14] Modi S,Svensson WE,Mortimer PS.Human lymphatic pumping measured in healthy and lymphoedematous arms by lymphatic congestion lymphoscintigraphy.J Physiol2007;583:271-85 PMCID:PMC2277237

[15] Tzani I,Zerva E,Dimakakos E.Physiotherapeutic rehabilitation of lymphedema: state-of-the-art.Lymphology2018;51:1-12.

[16] Földi E,Weissleder H.Conservative treatment of lymphoedema of the limbs.Angiology1985;36:171-80

[17] Hwang JM,Kim TW,Chang HJ.Long-term effects of complex decongestive therapy in breast cancer patients with arm lymphedema after axillary dissection.Ann Rehabil Med2013;37:690-7 PMCID:PMC3825946

[18] de Sire A,Lippi L.Surgical treatment and rehabilitation strategies for upper and lower extremity lymphedema: a comprehensive review.Medicina2022;58:954. PMCID:PMC9324426